Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01078805 · ClinicalTrials.gov registry record
Study of FORTEO Use in Subjects in the Community Setting
A clinical trial, sponsored by Eli Lilly and Company.
- Completed
- Registry status
- 4,167
- Enrollment target
NCT01078805 is a clinical trial that has completed, run by Eli Lilly and Company. The registered enrollment target is 4,167 participants.
The verdict
NCT01078805 has completed, sponsored by Eli Lilly and Company.
- COMPLETED
- Registry status
- 4,167 participants
- Enrollment target
Study Summary
The purpose of this study is to evaluate the long-term effectiveness, safety, and tolerability of FORTEO in a larger, more diverse "real world" population than studied in clinical trials
Interventions
- DRUG FORTEO
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 4,167 participants |
| Start Date | 2003-08 |
| Est. Completion | 2011-02 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01078805
The ClinicalTrials.gov registry entry for NCT01078805 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 4,167 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Eli Lilly and Company, which has 1,341 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which FORTEO is the first listed.
NCT01078805 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01078805 about?
NCT01078805 is a clinical study titled "Study of FORTEO Use in Subjects in the Community Setting". The purpose of this study is to evaluate the long-term effectiveness, safety, and tolerability of FORTEO in a larger, more diverse "real world" population than studied in clinical trials
What is the current status of trial NCT01078805?
This trial is currently completed. The enrollment target is 4,167 participants. The study started on 2003-08. Estimated completion is 2011-02.
What interventions are being tested in trial NCT01078805?
The interventions under investigation include: FORTEO (DRUG).
Who is sponsoring clinical trial NCT01078805?
This trial is sponsored by Eli Lilly and Company, which has 1,341 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.